Scientists have decoded the atomic-level secrets behind catalysts that turn propane into propylene. Their algorithms reveal unexpected oxide behavior that stabilizes the catalytic reaction by ...
Ionis has committed to a phase 3 programme for its antisense therapy for rare genetic disorder Angelman syndrome, just weeks after Biogen decided against exercising an option to license the drug. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback